Rchr
J-GLOBAL ID：202401013265031129
Update date: Sep. 07, 2024
Tanaka Akito
タナカ アキト | Tanaka Akito
Affiliation and department：
Job title：
Professor
Research field (2)：
Pharmaceuticals - chemistry and drug development
, Bioorganic chemistry
Research keywords (1)：
huhs015
Research theme for competitive and other funds (1)：
- 2015 - 2018 Drug discovery research for clinical application of PCA-1 inhibitors
Papers (52)：
-
Tadashi Shimizu, Keiko Yamaguchi, Momoka Yamamoto, Rina Kurioka, Yukari Kino, Wataru Matsunaga, Syuhei Nakao, Hiroshi Fukuhara, Akito Tanaka, Akinobu Gotoh, et al. Identification of HUHS190, a human naftopidil metabolite, as a novel anti-bladder cancer drug. Bioorganic & medicinal chemistry letters. 2020. 30. 1. 126744-126744
-
Masahiro Ueda, Tadashi Shimizu, Miyuki Mabuchi, Kota Horiike, Kaori Kitae, Hiroaki Hase, Yuko Ueda, Kazutake Tsujikawa, Akito Tanaka. Novel Metabolically Stable PCA-1/ALKBH3 Inhibitor Has Potent Antiproliferative Effects on DU145 Cells In Vivo. Anticancer research. 2018. 38. 1. 211-218
-
Syuhei Nakao, Miyuki Mabuchi, Shenglan Wang, Yoko Kogure, Tadashi Shimizu, Koichi Noguchi, Akito Tanaka, Yi Dai. Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor. Bioorganic & medicinal chemistry letters. 2017. 27. 14. 3167-3172
-
Taisuke Uehara, Yukinori Minoshima, Koji Sagane, Naoko Hata Sugi, Kaoru Ogawa Mitsuhashi, Noboru Yamamoto, Hiroshi Kamiyama, Kentaro Takahashi, Yoshihiko Kotake, Mai Uesugi, et al. Selective degradation of splicing factor CAPERα by anticancer sulfonamides. Nature chemical biology. 2017. 13. 6. 675-680
-
Miyuki Mabuchi, Masahiro Ueda, Yuri Yoshida, Kota Horiike, Kenta Yamaoka, Syuhei Nakao, Tadashi Shimizu, Yuko Ueda, Kazutake Tsujikawa, Akito Tanaka. Systematic Trial for Evaluating Docetaxel in a Human Prostate Cancer Cell DU145 Xenograft Model. Anticancer research. 2017. 37. 4. 1665-1676
ｍore...
Return to Previous Page
